Information and communication in the context of a clinical trial

By Hietanen P.   Aro A.R.   Holli K.   Absetz P.  

European Journal of Cancer, Vol. 36, Iss. 16, 2000-10 ,pp. : 2096-2104

Elsevier

Access to resources Recommend Favorite

How do doctors explain randomised clinical trials to their patients? - study of quality of information given to participants in a clinical trial

By Jenkins V.A.   Fallowfield L.J.   Souhami A.   Sawtell M.  

European Journal of Cancer, Vol. 35, Iss. 8, 1999-08 ,pp. : 1187-1193

Elsevier

Access to resources Recommend Favorite

Short-course adjuvant trastuzumab therapy in early stage breast cancer in Finland: Cost-effectiveness and value of information analysis based on the 5-year follow-up results of the FinHer Trial

By Purmonen Timo T.   Päänkäälääinen Emma   Turunen Juha H. O.   Asseburg Christian   Martikainen Janne A.  

Acta Oncologica, Vol. 50, Iss. 3, 2011-04 ,pp. : 344-352

Informa Healthcare

Access to resources Recommend Favorite

Can improved communication increase patient participation in randomised clinical trials?

By Sawka C.A.   Pritchard K.I.  

European Journal of Cancer, Vol. 37, Iss. 3, 2001-02 ,pp. : 297-299

Elsevier

Access to resources Recommend Favorite

New Omics Information for Clinical Trial Utility in the Primary Setting

By Damia Giovanna   Broggini Massimo   Marsoni Silvia   Venturini Sergio   Generali Daniele  

Journal of the National Cancer Institute Monographs, Vol. 2011, Iss. 43, 2011-10 ,pp. : 128-133

Oxford University Press

Access to resources Recommend Favorite